Physician profile
Anna L Rourke
NPI 1427426568
$9,633.39
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $496 · 2022: $785 · 2023: $1,984 · 2024: $6,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,800 · Food and Beverage: $2,077 · Travel and Lodging: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,800.00 |
| Food and Beverage | $2,077.14 |
| Travel and Lodging | $475.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $7,855.32 | 2022-2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $345.54 | 2021-2023 | |
| Abiomed | $344.60 | 2021-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.58 | 2023-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $199.78 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.09 | 2021-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $128.83 | 2023 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Amgen INC. | $113.94 | 2021-2022 | |
| Pfizer INC. | $43.94 | 2021 | |
| Lantheus Medical Imaging, INC. | $27.32 | 2023 | Definity |
| Esperion Therapeutics, INC. | $21.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Rourke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.